Viemed Healthcare US (DE:VIJ)
NASDAQ:VIJ
VIJ Stock Chart & Stats
€5.55
€0.10(1.36%)
At close: 4:00 PM EST
€5.55
€0.10(1.36%)
Day’s Range― - ―
52-Week Range€4.82 - €8.30
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€331.69M
Enterprise Value€379.91M
Total Cash (Recent Filing)€9.76M
Total Debt (Recent Filing)€12.44M
Price to Earnings (P/E)25.7
Beta0.36
Next Earnings
Aug 12, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.39
Shares Outstanding38,336,803
10 Day Avg. Volume20
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio0.62
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.4
Revenue Forecast (FY)€273.32M
Bulls Say, Bears Say
Bulls Say
High Gross & EBITDA MarginsViemed's consistently high gross margins and steady EBITDA margins reflect durable unit economics from rental and resupply businesses. High service-driven gross margins provide a cushion vs. reimbursement pressure, support reinvestment in clinical capabilities, and sustain profitability over the medium term.
Diversified, Recurring Revenue MixGrowth in PAP patients and rapidly expanding equipment & supply sales shift revenue away from ventilator concentration toward recurring resupply and sales. This diversification improves revenue predictability, reduces single-product dependency, and enhances capital efficiency across the home-care platform.
Conservative Balance Sheet & LiquidityVery low leverage and available credit capacity give Viemed flexibility for working capital, acquisitions, or weathering reimbursement cycles. Debt reduction and liquidity provide durable financial optionality, lowering default risk and enabling capital allocation to growth or shareholder returns over the medium term.
Bears Say
Ventilator Census & Policy Compliance RiskNew NCD compliance criteria have raised ventilator patient turnover and temporary loss risk, reducing the predictability of a historically large rental revenue stream. Given ventilators remain a material portion of revenue, sustained census pressure could depress recurring revenue and utilization over several quarters.
Volatile Free Cash Flow ConversionOperating cash flow is strong, but free cash flow has been inconsistent due to working-capital and investment timing. Irregular FCF conversion constrains predictable funding for capex, acquisitions, debt paydown, or buybacks, making capital allocation and balance-sheet strengthening less certain in the medium term.
Rising SG&A & Potential Equity DilutionAbsolute SG&A growth from integration and headcount raises the ongoing fixed-cost base, pressuring bottom-line conversion. An expanded long‑term incentive reserve supports retention but increases potential share-based dilution, which can dilute EPS and constrain per-share returns if issuance accelerates.
Viemed Healthcare News
VIJ FAQ
What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was €4.82 and its highest was €8.30 in the past 12 months.
What is Viemed Healthcare US’s market cap?
Viemed Healthcare US’s market cap is €331.69M.
When is Viemed Healthcare US’s upcoming earnings report date?
Viemed Healthcare US’s upcoming earnings report date is Aug 12, 2026 which is in 66 days.
How were Viemed Healthcare US’s earnings last quarter?
Viemed Healthcare US released its earnings results on May 05, 2026. The company reported €0.052 earnings per share for the quarter, missing the consensus estimate of €0.078 by -€0.026.
Is Viemed Healthcare US overvalued?
According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued.
Does Viemed Healthcare US pay dividends?
Viemed Healthcare US does not currently pay dividends.
What is Viemed Healthcare US’s EPS estimate?
Viemed Healthcare US’s EPS estimate is 0.1.
How many shares outstanding does Viemed Healthcare US have?
Viemed Healthcare US has 38,336,803 shares outstanding.
What happened to Viemed Healthcare US’s price movement after its last earnings report?
Viemed Healthcare US reported an EPS of €0.052 in its last earnings report, missing expectations of €0.078. Following the earnings report the stock price went down -7.051%.
Which hedge fund is a major shareholder of Viemed Healthcare US?
Currently, no hedge funds are holding shares in DE:VIJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
DE:VIJ Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €1.1M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
51.28%
12-Months-Change
Fundamentals
Return on Equity
10.66%
Trailing 12-Months
Asset Growth
10.83%
Trailing 12-Months
Company Description
Viemed Healthcare US
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
VIJ Company Deck
VIJ Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial progress: revenue growth of 28% YoY, substantial free cash flow improvement, meaningful scaling in sleep (PAP up 57% YoY) and maternal health expansion, improved capital efficiency and a stronger, more diversified revenue mix. Near-term headwinds are largely related to NCD-driven compliance effects in ventilation (higher turnover and temporary pressure on net census), some seasonality, and comparability issues from a prior-year gain. Management reiterated positive guidance, tightened revenue guidance upward, and highlighted continued margin and cash-flow improvement, indicating confidence in execution.View all DE:VIJ earnings summariesTechnical Analysis
Inogen
―
Senseonics Holdings
―
Tactile Systems Technology
―
Outset Medical
―
Bioventus
―
Options Prices
Currently, No data available
---